Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate or Modafinil for EDS in Children Post-Cancer
NCT01348607Phase 2Terminated
- Sponsor
- University of South Florida
- Start
- Jul 2010
- Primary completion
- Nov 2012
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of methylphenidate hydrochloride extended-release chewable tablet and modafinil in Excessive Daytime Sleepiness (EDS) (3 arms), sponsored by University of South Florida. Primary endpoint: Average Daytime Napping Minutes in a Week at 29 days. Started Jul 2010; status: terminated.
02
Drugs
methylphenidate hydrochloride extended-release chewable tabletmodafinil
03
Conditions
Excessive Daytime Sleepiness (EDS)
Beyond the preview
Go deeper on NCT01348607.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01348607.